Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety of using a combination of minimally
invasive surgery and clot lysis with rt-PA to remove intracerebral hemorrhage (ICH). The ICES
arm of the trial will determine the safety of endoscopic surgery to remove ICH. All MISTIE
intention to treat subjects represent the hypothesized test group. The ICES cohort is to be
analyzed separately.
Phase:
Phase 2
Details
Lead Sponsor:
Daniel Hanley
Collaborators:
Emissary International LLC Genentech, Inc. National Institute of Neurological Disorders and Stroke (NINDS)